Logo image of BLRX

BIOLINERX LTD-SPONS ADR (BLRX) Stock Analyst Ratings

USA - NASDAQ:BLRX - US09071M2052 - ADR

3.72 USD
+0.06 (+1.64%)
Last: 10/24/2025, 8:11:09 PM

Related screens

Up and Down Grades
Date Firm Action Rating
2025-06-17 HC Wainwright & Co. Reiterate Buy -> Buy
2025-05-30 Jones Trading Upgrade Hold -> Buy
2025-05-28 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-02 Jones Trading Downgrade Buy -> Hold
2025-03-31 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-25 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-04 Jones Trading Initiate Buy
2024-06-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-29 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-26 HC Wainwright & Co. Reiterate Buy -> Buy
2024-02-29 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-20 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-15 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-31 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-25 Oppenheimer Reiterate Outperform

BIOLINERX LTD-SPONS ADR / BLRX FAQ

How do analysts rate BIOLINERX LTD-SPONS ADR (BLRX)?

The consensus rating for BIOLINERX LTD-SPONS ADR (BLRX) is 100 / 100 . This indicates that analysts generally have a positive outlook on the stock.